Stock & Company Details
Acadia Pharmaceuticals Inc $ACAD
Price:
N/A
N/A
172M
$3.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
8.85
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ACAD technical indicators
Latest Acadia Pharmaceuticals Inc (ACAD) indicator readings as of 2026-10-08.
ACAD's 14-day RSI is 16.8, in oversold territory. ADX reads 47.7, indicating a trending market. MACD (12, 26, 9) is -2.19, below the zero line.
Overview
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Finance Bot
Ask your questions
Start by typing a question below.
